FDA officials have set a review date of June 30, 2025, to review avutometinib in combination with defactinib to treat ...

A systematic review and meta-analysis found some supporting evidence for transdermal anti-inflammatory patches, but the ...

The large pharmacy benefit managers have switched up their coverage of biosimilars, especially the biosimilars to Humira ...